Centric Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $399K | Hold |
3,525
| – | – | 0.06% | 153 |
|
|
2026
Q1 | $399K | Sell |
3,525
-716
| -17% | -$82.7K | 0.08% | 142 |
|
|
2025
Q4 | $481K | Sell |
4,241
-161
| -4% | -$15.1K | 0.1% | 130 |
|
|
2025
Q3 | $378K | Sell |
4,402
-25,194
| -85% | -$2.08M | 0.08% | 136 |
|
|
2025
Q2 | $2.39M | Buy |
29,596
+1,519
| +5% | +$121K | 0.57% | 63 |
|
|
2025
Q1 | $2.52M | Buy |
28,077
+4,075
| +17% | +$380K | 0.66% | 53 |
|
|
2024
Q4 | $2.39M | Buy |
24,002
+174
| +0.7% | +$17.9K | 0.65% | 47 |
|
|
2024
Q3 | $2.4M | Buy |
23,828
+379
| +2% | +$45K | 0.64% | 55 |
|
|
2024
Q2 | $2.94M | Buy |
23,449
+894
| +4% | +$115K | 0.85% | 37 |
|
|
2024
Q1 | $2.91M | Buy |
22,555
+1,246
| +6% | +$154K | 0.93% | 32 |
|
|
2023
Q4 | $2.69M | Buy |
21,309
+1,313
| +7% | +$136K | 0.89% | 29 |
|
|
2023
Q3 | $2.06M | Buy |
19,996
+844
| +4% | +$91K | 0.86% | 30 |
|
|
2023
Q2 | $2.11M | Buy |
19,152
+531
| +3% | +$60.3K | 0.84% | 30 |
|
|
2023
Q1 | $1.98M | Sell |
18,621
-591
| -3% | -$63.8K | 0.86% | 30 |
|
|
2022
Q4 | $2.13M | Sell |
19,212
-522
| -3% | -$53.4K | 1.08% | 24 |
|
|
2022
Q3 | $1.7M | Buy |
19,734
+290
| +1% | +$25.9K | 0.68% | 37 |
|
|
2022
Q2 | $1.77M | Buy |
19,444
+471
| +2% | +$41.8K | 0.65% | 39 |
|
|
2022
Q1 | $1.56M | Buy |
18,973
+703
| +4% | +$55.4K | 0.49% | 52 |
|
|
2021
Q4 | $1.4M | Buy |
18,270
+1,389
| +8% | +$111K | 0.46% | 62 |
|
|
2021
Q3 | $1.27M | Buy |
16,881
+314
| +2% | +$23.9K | 0.47% | 56 |
|
|
2021
Q2 | $1.29M | Sell |
16,567
-12,929
| -44% | -$962K | 0.45% | 58 |
|
|
2021
Q1 | $2.17M | Buy |
29,496
+1,402
| +5% | +$103K | 0.62% | 44 |
|
|
2020
Q4 | $2.19M | Buy |
28,094
+17,755
| +172% | +$1.36M | 0.68% | 35 |
|
|
2020
Q3 | $805K | Sell |
10,339
-2,831
| -21% | -$222K | 0.61% | 43 |
|
|
2020
Q2 | $972K | Buy |
13,170
+2,831
| +27% | +$213K | 0.51% | 53 |
|
|
2020
Q1 | $805K | Sell |
10,339
-349
| -3% | -$27.4K | 0.61% | 43 |
|
|
2019
Q4 | $927K | Buy |
10,688
+349
| +3% | +$28.7K | 0.74% | 38 |
|
|
2019
Q3 | $805K | Buy |
10,339
+640
| +7% | +$51.3K | 0.61% | 43 |
|
|
2019
Q2 | $776K | Buy |
9,699
+138
| +1% | +$10.6K | 0.68% | 41 |
|
|
2019
Q1 | $759K | Sell |
9,561
-5,936
| -38% | -$444K | 0.7% | 39 |
|
|
2018
Q4 | $1.13M | Buy |
+15,497
| New | +$1.09M | 0.99% | 18 |
|
Other funds holding MRK
Centric Wealth Management's MRK Position: Q2 2026 in Review
Centric Wealth Management held its Merck (MRK) position steady in Q2 2026 at 3,525 shares worth $399K. The position accounts for 0.06% of the portfolio, ranked #153.
Centric Wealth Management first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.94M in Q2 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Centric Wealth Management held 3,525 shares of Merck worth $399K as of Q2 2026.
- Centric Wealth Management left its Merck share count unchanged in Q2 2026.
- Merck made up 0.06% of Centric Wealth Management's portfolio in Q2 2026, its #153 holding.
- Centric Wealth Management first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Centric Wealth Management's Merck position peaked at $2.94M in Q2 2024.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Centric Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.